Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Benz

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Dermatology|March 12, 2014
Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related?Mirjana Urosevic-Maiwald, Stephan Nobbe, Katrin Kerl, et al.
European Journal of Haematology|December 17, 2008
Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemiaRudolf Benz, Raffaele Daniele Siciliano, Georg Stussi, et al.
Hemasphere|July 15, 2021
Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 VaccineMarie-Estelle Gaignard, Sven Lieberherr, Andreas Schoenenberger, et al.
British Journal of Haematology|April 21, 2018
Neisseria elongata infection associated with complement inhibition during treatment of paroxysmal nocturnal haemoglobinuriaRudolf Benz, Martin Krause, Sabine Majer, et al.
Annals of Hematology|June 13, 2006
Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapyJeroen S Goede, Rudolf Benz, Joerg Fehr, et al.
Leukemia Research|January 2, 2008
G-CSF-induced remission in two cases of acute myeloid leukemiaRudolf Benz, Jeroen S Goede, Valérie Parlier, et al.
Practical Neurology|November 20, 2009
When a clear crystal makes a case crystal clearRudolf Benz, Rudolf Bena, Max Züger, et al.
Annals of Hematology|February 20, 2017
sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-α therapyStéphanie Jud, Jeroen S Goede, Oliver Senn, et al.
Leukemia & Lymphoma|May 26, 2020
Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosisRudolf Benz, Kathrin Zimmermann, Markus Rechsteiner, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 7, 2015
Efficacy of Azacitidine in De Novo and Relapsed Acute Myeloid Leukemia: A Retrospective Comparative StudyCornelia Gemuenden, Rudolf Benz, Oliver Senn, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Dermatology|March 12, 2014
Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related?Mirjana Urosevic-Maiwald, Stephan Nobbe, Katrin Kerl, et al.
European Journal of Haematology|December 17, 2008
Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemiaRudolf Benz, Raffaele Daniele Siciliano, Georg Stussi, et al.
Hemasphere|July 15, 2021
Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 VaccineMarie-Estelle Gaignard, Sven Lieberherr, Andreas Schoenenberger, et al.
British Journal of Haematology|April 21, 2018
Neisseria elongata infection associated with complement inhibition during treatment of paroxysmal nocturnal haemoglobinuriaRudolf Benz, Martin Krause, Sabine Majer, et al.
Annals of Hematology|June 13, 2006
Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapyJeroen S Goede, Rudolf Benz, Joerg Fehr, et al.
Leukemia Research|January 2, 2008
G-CSF-induced remission in two cases of acute myeloid leukemiaRudolf Benz, Jeroen S Goede, Valérie Parlier, et al.
Practical Neurology|November 20, 2009
When a clear crystal makes a case crystal clearRudolf Benz, Rudolf Bena, Max Züger, et al.
Annals of Hematology|February 20, 2017
sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-α therapyStéphanie Jud, Jeroen S Goede, Oliver Senn, et al.
Leukemia & Lymphoma|May 26, 2020
Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosisRudolf Benz, Kathrin Zimmermann, Markus Rechsteiner, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 7, 2015
Efficacy of Azacitidine in De Novo and Relapsed Acute Myeloid Leukemia: A Retrospective Comparative StudyCornelia Gemuenden, Rudolf Benz, Oliver Senn, et al.
Pageof 4